Founded
Address
Boston Millennia Partners LP
30 Rowes Wharf
Suite 400
Boston, MA 02110
United States
Phone
Email
Website
Recent investment activity
KANDO id: 19181
Fund terms
Fund manager
Vintage
1998
Funding rounds
Fund Closing USD 175,000,000
USD 175,000,000 ( )
| Investor | Profile | Country | |
|---|---|---|---|
|
SITRA (Finnish Innovation Fund) | Independent public fund which, under the supervision of the Finnish Parliament, promotes the welfare of Finnish society | |
|
State of Wisconsin Investment Board (SWIB) | Agency responsible for managing the assets of the Wisconsin Retirement System (WRS), the State Investment Fund (SIF) and other state trust funds |
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 46| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Arthrosurface Inc | Arthrosurface, Inc. was organized in 2002 to develop surgical alternatives for the treatment of orthopedic joint disease. | N/A | |||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series C | |||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series B | |||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series A | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | N/A | |||
|
|
Collegium Pharmaceutical Inc | Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company. | N/A | |||
|
|
CombinatoRx Inc | Biopharmaceutical company. | N/A USD 30,000,000 (USD 30,000,000) | |||
|
|
Constellar Corp | N/A | ||||
|
|
Deltagen Bioservices Inc | Provider of drug discovery tools and services. | N/A | |||
|
|
eMed Technologies Inc | eMed Technologies, Inc., privately held, offers a complete technology solution for improving the business of radiology. | N/A | |||
|
|
EpiGenesis Pharmaceuticals Inc | EpiGenesis Pharmaceuticals is a drug discovery and development company focused on respiratory disease. | N/A | |||
|
|
EPIX Pharmaceuticals Inc | Series C USD 43,000,000 (USD 43,000,000) | ||||
|
|
Fogdog Sports Inc (Fogdog Inc) | N/A | ||||
|
|
Galt Associates Inc | Galt Associates, Inc. is a pharmacovigilance support company. | N/A | |||
|
GlycoFi Inc | N/A | ||||
|
|
Histogenics Corp | Histogenics Corporation expertise and focus is on repairing articular cartilage damage. | N/A | |||
|
|
Histogenics Corp | Histogenics Corporation expertise and focus is on repairing articular cartilage damage. | N/A USD 13,300,000 (USD 13,300,000) | |||
|
|
ILEX Oncology Inc | N/A | ||||
|
McKesson Corp | N/A | ||||
|
|
MedAptus Inc | MedAptus is a healthcare information technology company. | N/A | |||
|
|
Neoworld Communications Inc | Two-way radio dispatch service provider | Series A | |||
|
|
net.Genesis Corp | E-business intelligence software company and services that empower companies that market, sell and support products on the web. | N/A | |||
|
|
Nexidia Inc | Venture | ||||
|
|
Novalar Pharmaceuticals Inc | Novalar is developing a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures. | N/A | |||
|
|
NuVox Inc | Integrated communications provider | N/A |
Team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Brian Walsh | Nth Power LLC |